Skip to main content
PCL. Inc logo

PCL. Inc — Investor Relations & Filings

Ticker · 241820 ISIN · KR7241820000 KO Manufacturing
Open in API
Filings indexed 684 across all filing types
Latest filing 2022-12-13 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 241820

About PCL. Inc

http://www.pclchip.com/

PCL, Inc. is a company that develops and manufactures in-vitro diagnostic (IVD) medical devices, specializing in multiplex immunodiagnosis. The company's core offering is based on its proprietary SG Cap™ Technology, a platform for creating advanced diagnostic solutions. Its product portfolio includes automated multi-immune diagnostic systems, blood testing kits, cancer screening tests, and rapid antigen kits. PCL also provides platform services, reagents, and related equipment such as desktop arrayers to the medical and diagnostic fields.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from a Korean company (PCL Inc.) regarding a 'Capital Increase Decision' (유상증자결정). It specifically details a correction (정정신고) to a previously filed capital increase plan, explaining the shift from a payment-in-kind method to a cash-based third-party allocation. This falls under the category of announcements regarding new share issues and capital structure changes.
2022-12-13 Korean
[기재정정]주요사항보고서(타법인주식및출자증권양수결정)
M&A Activity Classification · 100% confidence The document is a regulatory filing submitted to the Korea Exchange (KRX) regarding a correction to a previous disclosure ('정정신고') concerning the acquisition of shares in another corporation ('타법인 주식 및 출자증권 양수결정'). This type of disclosure is a standard regulatory requirement for listed companies to report material corporate events, such as M&A activity or significant investments. Since it does not fit into specific categories like M&A (which usually implies a takeover bid or merger proposal) or other specialized categories, it falls under the general regulatory filing category.
2022-12-13 Korean
[기재정정]주요사항보고서(타법인주식및출자증권양수결정)
M&A Activity Classification · 100% confidence The document is a regulatory filing submitted to the Korea Exchange (KRX) regarding the withdrawal of a previous decision to acquire shares in another corporation (M-Curex Co., Ltd.). It follows the standard format for a 'Major Report' (주요사항보고서) in the Korean market, specifically detailing a change in corporate strategy regarding an investment. Since it is a specific regulatory disclosure regarding a corporate transaction (M&A/Investment activity) that does not fit into the other specific categories like 'TAR' (which usually implies a definitive merger/takeover announcement) or 'RPA', it is best classified as a general regulatory filing.
2022-12-12 Korean
타법인주식및출자증권취득결정
M&A Activity Classification · 100% confidence The document is a regulatory filing from a Korean company (PCL) announcing the acquisition of shares in another company (M-Curex). This type of disclosure, detailing the acquisition of equity securities in another entity, is classified as a corporate transaction or regulatory filing. Since it does not fit into specific categories like M&A (which usually implies a merger or takeover of the whole entity) or share issuance, it falls under the general regulatory filing category.
2022-12-12 Korean
[기재정정]주요사항보고서(유상증자결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean Financial Supervisory Service and Korea Exchange. It specifically details a 'Decision on Paid-in Capital Increase' (유상증자결정) and includes a 'Correction Report' (정정신고) regarding the terms of the capital increase, such as the number of shares, purpose of funds, and third-party allocation details. This falls under the category of capital structure changes and financing updates.
2022-12-12 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from a Korean company (PCL Inc.) regarding a decision on a paid-in capital increase (유상증자결정). It details the issuance of new shares, the purpose of the capital raise, and the third-party allocation details. This falls under the category of share issuance and capital changes.
2022-12-12 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.